期刊文献+

Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer 被引量:6

Catheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer
下载PDF
导出
摘要 AIM: To assess the catheterization-associated complications during intraperitoneal chemotherapy (IPCT) for advanced gastric cancer.METHODS: From 1998 to 2002, 80 patients with advanced gastric cancer received a total of 320 courses of IPCT using a large bore central venous catheter and associated complications were analyzed.RESULTS: Catheterization-associated complications occurred in 11 of the 80 patients (13.8%), including abdominal pain caused by catheter in 2 cases (0.63%), insertion failure in 2 cases (0.63%), bowel perforation in 1 case (0.31%) and abdominal pain during chemotherapy in 6 cases (1.88%).No serious complications required surgical intervention.CONCLUSION: IPCT using central venous catheters can be performed safely and simply without severe associated complications. AIM:To assess the catheterization-associated complications during intraperitoneal chemotherapy (IPCT) for advanced gastric cancer. METHODS:From 1998 to 2002,80 patients with advanced gastric cancer received a total of 320 courses of IPCT using a large bore central venous catheter and associated complications were analyzed. RESULTS:Catheterization-associated complications occurred in 11 of the 80 patients (13.8%),including abdominal pain caused by catheter in 2 cases (0.63%),insertion failure in 2 cases (0.63%),bowel perforation in 1 case (0.31%) and abdominal pain during chemotherapy in 6 cases (1.88%). No serious complications required surgical intervention. CONCLUSION:IPCT using central venous catheters can be performed safely and simply without severe associated complications.
机构地区 CenterforOncology
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第9期1372-1374,共3页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献15

  • 1Yutaka Yonemura M.D.,Tosiharu Sawa M.D.,Kazuo Kinoshita M.D.,Nobuo Matsuki M.D.,Sachio Fushida M.D.,Sigehiro Tanaka M.D.,Shigekazu Ohoyama M.D.,Tooru Takashima M.D.,Hironobu Kimura M.D.,Tooru Kamata M.D.,Takashi Fujimura M.D.,Kazuo Sugiyama M.D.,Kouzou Shima M.D.,Itsuo Miyazaki.Neoadjuvant chemotherapy for high-grade advanced gastric cancer[J].World Journal of Surgery.1993(2)
  • 2Yutaka Yonemura M.D.,Takashi Fujimura M.D.,Sachio Fushida M.D.,Shigeru Takegawa M.D.,Toru Kamata M.D.,Kanji Katayama M.D.,Takeo Kosaka M.D.,Akio Yamaguchi M.D.,Kouichi Miwa M.D.,Ituo Miyazaki M.D.Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination[J].World Journal of Surgery.1991(4)
  • 3Prof. Dr. Peter Schlag M.D.Adjuvant chemotherapy in gastric cancer[J].World Journal of Surgery.1987(4)
  • 4J. W. L. Fielding F.R.C.S.,S. L. Fagg F.R.C.S.,B. G. Jones F.R.C.S.,D. Ellis F.R.C.S.,M. S. Hockey F.R.C.S.,A. Minawa Ph.D.,V. S. Brookes F.R.C.S.,J. L. Craven M.D., F.R.C.S.,M. C. Mason F.R.C.S.,A. Timothy M.R.C.P., F.R.C.R.,J. A. H. Waterhouse Ph.D.,P. F. M. Wrigley Ph.D., F.R.C.P.An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer group[J].World Journal of Surgery.1983(3)
  • 5Lise M,Nitti D,Marcher A,Sahmoud T,Buyse M,Duez N,Fiorentino M,Santos JGD,Labianca R,Rougier P,Gignoux M.Final results of aphase Ⅲ clinical trial of adjuvant chemotherapy with the modified fluorouracil,doxorubicin,and mitomycin regimen in resectable gastric cancer[].Journal of Clinical Oncology.1995
  • 6Neri B,Leonardis VD,Romano S,Andreoli F,Pernice LM,Bruno L,Borrelli D,Valeri A,Fabbroni S,Intini C,Cini G.Adjuvant chemotherapy after gastric resection in node-positive cancer patients:a multicentre randomised study[].British Journal of Cancer.1996
  • 7Coombes RC,Schein PS,Chilvers CED,Wils J,Beretta G,Bliss JM,Rutten A,Amadori D,Cortes-Funes H,Villar-Grimalt A,Mefterfle C,Rauschecker HF,Boven E,Vassilopoulos P,Welvaart K,Ferreira EP,Wiig J,Gisselbrecht C,Rougier P,Woods EMA.A randomized trial comparing adjuvant fluorouracil,doxorubicin,and mitomycin with no treatment in operable gastric cancer[].Journal of Clinical Oncology.1990
  • 8Fink U,Schuhmacher C,Stein HJ,Busch R,Feussner H,Dittler HJ,Helmberger A,Bottcher K,Siewert JR.Preoperative chemotherapy for stage Ⅲ-Ⅳ gastric carcinoma:feasibility,response and outcome after complete resection[].British Journal of Surgery.1995
  • 9Haas CD,Mansfield CM,Leichman LP,Considine B,Bukowski RM.Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU,Doxorubicin,and Mitomycin for residual localized gastric adenocarcinoma:a southwest oncology group pilot study[].Cancer Treatment Reports.1983
  • 10Wang X,Lau M,Shi YQ,Lu J,Zhong YX,Wu HP,Zai HH,Ding J,Wu KC,Pan BR,Jin JP,Fan DM.Differential display of vincristine-resistance-related genesin gastric caocel SGC7901 cell[].World Journal of Gastroenterology.2002

共引文献36

同被引文献16

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部